These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10885710)

  • 21. Ga-67 scintigraphy in patients with breast lymphoma.
    Nishiyama Y; Yamamoto Y; Fukunaga K; Satoh K; Ohkawa M
    Clin Nucl Med; 2002 Feb; 27(2):101-4. PubMed ID: 11786738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy.
    Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
    Radiology; 2000 Jan; 214(1):253-7. PubMed ID: 10644133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of hematopoietic uptake by granulocyte colony-stimulating factor in Ga-67 scintigraphy.
    Kondoh H; Murayama S; Kozuka T; Nishimura T
    Clin Nucl Med; 1995 Mar; 20(3):250-3. PubMed ID: 7538455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ga-67 imaging in the diagnosis and management of primary non-Hodgkin's lymphoma of the larynx.
    Khoury J; Jerushalmi J; Cohen HI; Nasrallah S
    Clin Nucl Med; 2002 Jan; 27(1):63-4. PubMed ID: 11805494
    [No Abstract]   [Full Text] [Related]  

  • 25. Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP).
    Wells JD; Huskison WT; Davenport OL
    South Med J; 1986 Oct; 79(10):1293-6. PubMed ID: 3464101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
    J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When is hilar uptake of 67Ga-citrate indicative of residual disease after CHOP chemotherapy?
    Frohlich DE; Chen JL; Neuberg D; Kehoe KM; Van den Abbeele AD
    J Nucl Med; 2000 Feb; 41(2):269-74. PubMed ID: 10688110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphoma.
    Israel O; Mor M; Epelbaum R; Frenkel A; Haim N; Dann EJ; Gaitini D; Bar-Shalom R; Kolodny GM; Front D
    Cancer; 2002 Feb; 94(4):873-8. PubMed ID: 11920453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
    Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
    Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applications of gallium-67 scintigraphy in the management of patients with malignant lymphoma.
    Fox K; Silfen D; Alavi A
    J Nucl Med; 1991 Dec; 32(12):2299-305. PubMed ID: 1720816
    [No Abstract]   [Full Text] [Related]  

  • 31. Gallium 67 imaging in monitoring lymphoma response to treatment.
    Israel O; Front D; Lam M; Ben-Haim S; Kleinhaus U; Ben-Shachar M; Robinson E; Kolodny GM
    Cancer; 1988 Jun; 61(12):2439-43. PubMed ID: 3365666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Case of reticulum cell sarcoma of the mesentery--with special reference to the gallium scintigram].
    Itai Y; Hachiya J; Kogure T; Miyamae T
    Rinsho Hoshasen; 1973 Nov; 18(12):984-90. PubMed ID: 4589443
    [No Abstract]   [Full Text] [Related]  

  • 33. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma.
    Gasparini M; Bombardieri E; Castellani M; Tondini C; Maffioli L; Devizzi L; Gerundini P
    J Nucl Med; 1998 Sep; 39(9):1586-90. PubMed ID: 9744348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing biodistribution of gallium during G-CSF treatment in non- Hodgkin's disease.
    Maffioli LS; Castellani MR; Bombardieri E; Devizzi L; Draisma A; Pauwels E
    Eur J Nucl Med; 1999 Jan; 26(1):68-9. PubMed ID: 10048953
    [No Abstract]   [Full Text] [Related]  

  • 35. Ga-67 scintigraphy in a patient with B-cell lymphoma.
    Waldherr C; Otte A; Mueller-Brand J
    Clin Nucl Med; 2000 May; 25(5):389. PubMed ID: 10795710
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatic photopenia in gallium imaging.
    Glaser AM; Chen DC; Siegel ME
    Clin Nucl Med; 1988 Jul; 13(7):502-5. PubMed ID: 3048831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term intensive therapy for childhood non-Hodgkin lymphoma.
    Lancet; 1987 Jun; 1(8547):1410-2. PubMed ID: 2884500
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant lymphoma in the mesentery with immune thrombocytopenia.
    Moriwaki Y; Naka M; Yamamoto T; Takagi S; Hidaka T; Takahashi S; Hada T; Nishigami T; Higashino K
    Intern Med; 1992 Oct; 31(10):1185-9. PubMed ID: 1286224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging.
    Song EJ; Torok J; Wu Y; Chino J; Prosnitz LR; Beaven AW; Kelsey CR
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):145-151. PubMed ID: 29358045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.
    Small EJ; Venook AP; Damon LE
    Cancer; 1993 Aug; 72(3):905-8. PubMed ID: 8334644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.